A formulary for pediatric oncology in developing countries

Pediatric Blood and Cancer

Volumn 44, Issue 5, 2005, Pages 433-435

  Barr, Ronald D ^a,b   Sala, Alessandra ^a,c   Wiernikowski, John ^b   Masera, Giuseppe ^c   Mato, Gabriel ^d   Antillon, Federico ^e   Castillo, Luis ^f   Petrilli, Sergio ^g   Quintana, Juan ^h   Ribeiro, Raul ⁱ   Agarwal, Bharat ^j   Hesseling, Peter ^k  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER CHILDREN S HOSPITAL   (Canada)

^c SAN GERARDO HOSPITAL   (Italy)

^d HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^e Unidad Nacional de Oncologia Pediatrica   (Guatemala)

^f Centro Hospitalario Pereira Rossell   (Uruguay)

^g Instituto de Oncologia Pediatrica   (Brazil)

^h CLÍNICA LAS CONDES   (Chile)

ⁱ ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^j B J WADIA HOSPITAL FOR CHILDREN   (India)

^k STELLENBOSCH UNIVERSITY   (South Africa)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALLOPURINOL; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; AMPICILLIN; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIEMETIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; ANTIPROTOZOAL AGENT; ANTIVIRUS AGENT; ARABINOSIDE; ASPARAGINASE; BLEOMYCIN; BUSULFAN; CANNABINOID; CARBAMAZEPINE; CARBOPLATIN; CARMUSTINE; CEFAZOLIN; CEFIXIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORHEXIDINE; CIPROFLOXACIN; CLINDAMYCIN; CLOTRIMAZOLE; CLOXACILLIN; COTRIMOXAZOLE; DACARBAZINE; DACTINOMYCIN; DAPSONE; DAUNORUBICIN; DEXAMETHASONE; DIAZEPAM; DIMENHYDRINATE; DOXORUBICIN; ETOPOSIDE; FAMCICLOVIR; FENTANYL; FLUCONAZOLE; FOLINIC ACID; GABAPENTIN; GENTAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROCORTISONE; HYDROMORPHONE; HYDROXYUREA; IBUPROFEN; IFOSFAMIDE; IMMUNOSUPPRESSIVE AGENT; IRINOTECAN; KETAMINE; KETOCONAZOLE; LAMOTRIGINE; LOMUSTINE; LORAZEPAM; MELPHALAN; MERCAPTOPURINE; MESNA; METHADONE; METHOTREXATE; METHYLPREDNISOLONE; METOCLOPRAMIDE; METRONIDAZOLE; MIDAZOLAM; MITOXANTRONE; MORPHINE; NABILONE; NAPROXEN; NYSTATIN; ONDANSETRON; PARACETAMOL; PENICILLIN DERIVATIVE; PENTAMIDINE; PIPERACILLIN; POLYENE ANTIBIOTIC AGENT; PREDNISONE; PROCARBAZINE; PYRROLE DERIVATIVE; RETINOIC ACID; SEROTONIN 3 ANTAGONIST; STEROID; TENIPOSIDE; THIOPENTAL; TOBRAMYCIN; TOPOTECAN; VALACICLOVIR; VALPROIC ACID; VANCOMYCIN; VINBLASTINE; VINCRISTINE;

ANALGESIA; CANCER ADJUVANT THERAPY; CHILD; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DRUG EFFICACY; DRUG FORMULARY; DRUG UTILIZATION; HUMAN; MEDICAL SOCIETY; MEDICAL SPECIALIST; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH;

ANTINEOPLASTIC AGENTS; CHILD; DEVELOPING COUNTRIES; HUMANS; NEOPLASMS; PATIENT RIGHTS; WORLD HEALTH ORGANIZATION;

EID: 20944434578     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20367     Document Type: Note

References (15)

1. Barr RD, Ribeiro RC, Agarwal BR, et al. Pediatric oncology in countries with limited resources. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology, 4th edn. Philadelphia: Lippincott Williams and Wilkins; 2002. pp 1541-1552.
2. Sikora K. Developing a global strategy for cancer. Eur J Cancer 1999;35:1870-1877.
3. Bleyer A. The impact of childhood cancer on the United States and the world. CA Cancer J Clin 1990;40:355-367.
4. Wagner HP, Antic V. The problem of pediatric malignancies in the developing world. Ann NY Acad Sci 1997;824:193-204.
5. International Society of Paediatric Oncology. Paediatric oncology in low income countries. The Montevideo Document. SIOP News, October 1995.
6. Masera G, Baez F, Biondi A, et al. Bridging the childhood cancer mortality gap between economically developed and low-income countries: Lessons from the MISPHO experience. In: Tannenberger S, Cavalli F, Pannut F, editors. Cancer in developing countries. The great challenge for oncology in the 21st century. Muenchen-Bern-Wien-New York: W Zuckschwerdt Verlag; 2004. pp 42-60.
7. Essential drugs for cancer chemotherapy: Memorandum from a WHO meeting. Bull WHO 1985;63:999-1002.
8. WHO Consultation. Essential drugs for cancer chemotherapy. Bull WHO 1994;72:693-698.
9. Sikora K, Advani S, Koroltchouk V, et al. Essential drugs for cancer therapy: A World Health Organization consultation. Ann Oncol 1999;10:385-390.
10. Wagner HP. Cancer in childhood and supportive care. Supp Care Cancer 1999;7:293-294.
11. The selection and use of essential medicines. Report of the WHO Expert Committee, 2003. WHO Technical Report Series, World Health Organization, Geneva 2004.
12. Pui C-H, Schrappe M, Masera G, et al. Ponte di Legno Working Group: statement on the right of children with leukemia to have full access to essential treatment and report on the Sixth International Childhood Acute Lymphoblastic Leukemia Workshop. Leukemia 2004;18:1043-1053.
13. 2004 World Development Indicators. International Bank for Reconstruction and Development/ The World Bank. Washington, DC 2004.
14. Barr RD, Wiernikowski T, Mato G. Pediatric oncology in emerging nations: A challenge for clinical pharmacy. UICC News October 1998.
15. Sala A, Barr RD, Masera G. A survey of resources and activity in the MISPHO family of institutions in Latin America: A comparison of two eras. Pediatric Blood and Cancer 2004;43:758-764.